Dr Anna Minchom is a Consultant Medical Oncologist and BRC Clinical Scientist in the Drug Development Unit at the Royal Marsden Hospital and the Institute of Cancer Research, and the Lung Unit at the Royal Marsden Hospital.

Dr Minchom completed her undergraduate medical training in the University of Wales College of Medicine, qualifying in 2003. She was awarded MRCP in 2008. She trained in medical oncology at the Royal Marsden Hospital during which time she completed laboratory research investigating mechanisms of resistance to targeted drugs in non-small cell lung cancer, for which she was awarded an MD(res).

Dr Minchom is principal investigator on early phase drug trials including first-in-human clinical trials. Her main research focus is using a biomarker-driven and translational approach to develop novel drugs and drug combinations

Anna Minchom

Institute of Cancer Research and the Royal Marsden Hospital, London

Topic: Targeting RET and MET Positive Advanced NSCLC